Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.
In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.
Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.
The report details the trend, potential and market size of Gene Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapymarket, defines the market attractiveness level of Gene Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy industry, describes the types of Gene Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy market and the development prospects and opportunities of Gene Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy market in Chapter 13.
By Player:
Dimension Therapeutics
Spark Therapeutics
Celladon
Vical
Advantagene
Sangamo
Avalanche Bio
By Type:
Lentivirus
AAV
Retrovirus & Gammaretrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
By End-User:
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy Consumption (2017-2022)
-
7.2 United States Gene Therapy Consumption (2017-2022)
-
7.3 Europe Gene Therapy Consumption (2017-2022)
-
7.4 China Gene Therapy Consumption (2017-2022)
-
7.5 Japan Gene Therapy Consumption (2017-2022)
-
7.6 India Gene Therapy Consumption (2017-2022)
-
7.7 South Korea Gene Therapy Consumption (2017-2022)
8 Region and Country-wise Gene Therapy Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy Consumption Forecast (2022-2028)
9 Global Gene Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lentivirus Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AAV Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Retrovirus & Gammaretrovirus Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Modified Herpes Simplex Virus Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Adenovirus Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Non-viral Plasmid Vector Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Lymphoblastic Leukemia (ALL) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inherited Retinal Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Large B-cell Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global ADA-SCID Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Melanoma (Lesions) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Beta-Thalassemia Major/SCD Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Head & Neck Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Others Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Lentivirus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AAV Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Retrovirus & Gammaretrovirus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Modified Herpes Simplex Virus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Non-viral Plasmid Vector Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Lymphoblastic Leukemia (ALL) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Inherited Retinal Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Large B-cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global ADA-SCID Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Melanoma (Lesions) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Beta-Thalassemia Major/SCD Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Head & Neck Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy Market Competitive Analysis
-
14.1 Dimension Therapeutics
-
14.1.1 Dimension Therapeutics Company Details
-
14.1.2 Dimension Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dimension Therapeutics Gene Therapy Product and Service
-
14.2 Spark Therapeutics
-
14.2.1 Spark Therapeutics Company Details
-
14.2.2 Spark Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Spark Therapeutics Gene Therapy Product and Service
-
14.3 Celladon
-
14.3.1 Celladon Company Details
-
14.3.2 Celladon Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celladon Gene Therapy Product and Service
-
14.4 Vical
-
14.4.1 Vical Company Details
-
14.4.2 Vical Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Vical Gene Therapy Product and Service
-
14.5 Advantagene
-
14.5.1 Advantagene Company Details
-
14.5.2 Advantagene Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Advantagene Gene Therapy Product and Service
-
14.6 Sangamo
-
14.6.1 Sangamo Company Details
-
14.6.2 Sangamo Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sangamo Gene Therapy Product and Service
-
14.7 Avalanche Bio
-
14.7.1 Avalanche Bio Company Details
-
14.7.2 Avalanche Bio Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Avalanche Bio Gene Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy
-
Figure Gene Therapy Picture
-
Table Global Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy Consumption by Country (2017-2022)
-
Figure United States Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lentivirus Consumption and Growth Rate (2017-2022)
-
Figure Global AAV Consumption and Growth Rate (2017-2022)
-
Figure Global Retrovirus & Gammaretrovirus Consumption and Growth Rate (2017-2022)
-
Figure Global Modified Herpes Simplex Virus Consumption and Growth Rate (2017-2022)
-
Figure Global Adenovirus Consumption and Growth Rate (2017-2022)
-
Figure Global Non-viral Plasmid Vector Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Lymphoblastic Leukemia (ALL) Consumption and Growth Rate (2017-2022)
-
Figure Global Inherited Retinal Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Large B-cell Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global ADA-SCID Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma (Lesions) Consumption and Growth Rate (2017-2022)
-
Figure Global Beta-Thalassemia Major/SCD Consumption and Growth Rate (2017-2022)
-
Figure Global Head & Neck Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lentivirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AAV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retrovirus & Gammaretrovirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Modified Herpes Simplex Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-viral Plasmid Vector Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Lymphoblastic Leukemia (ALL) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inherited Retinal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large B-cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ADA-SCID Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma (Lesions) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta-Thalassemia Major/SCD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head & Neck Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Dimension Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Dimension Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dimension Therapeutics Gene Therapy Product and Service
-
Table Spark Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Gene Therapy Product and Service
-
Table Celladon (Foundation Year, Company Profile and etc.)
-
Table Celladon Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celladon Gene Therapy Product and Service
-
Table Vical (Foundation Year, Company Profile and etc.)
-
Table Vical Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vical Gene Therapy Product and Service
-
Table Advantagene (Foundation Year, Company Profile and etc.)
-
Table Advantagene Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advantagene Gene Therapy Product and Service
-
Table Sangamo (Foundation Year, Company Profile and etc.)
-
Table Sangamo Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Gene Therapy Product and Service
-
Table Avalanche Bio (Foundation Year, Company Profile and etc.)
-
Table Avalanche Bio Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avalanche Bio Gene Therapy Product and Service
-
